4. Antiplatelet Drugs Flashcards

(69 cards)

1
Q

Platelets do not have a nucleus. (T/F)

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where do platelets originate?

A

megakaryocytes from the bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the life span of a platelet?

A

~ 10 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a normal platelet count?

A

150,000 – 450,000 / μL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 4 main mechanisms that activate platelets?

A
  • underlying disease
  • endothelial injury
  • collagen
  • von Willebrand factor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Agonists bind to platelet receptors that initiate a signaling cascade that results in:

A
  • platelet shape change
  • granule release
  • thromboxane A2 generation
  • GP IIb/IIIa receptor activation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the platelet receptors that initiate activation?

A

glycoprotein IIb/IIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are potent platelet activation agonists?

A
  • binding to collagen after vascular damage

- thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are weak platelet activation agonists?

A
  • ADP
  • TxA2
  • Epinephrine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Platelets are activated by what G proteins?

A
  • q and i

- G (12/13) families

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Platelets are inhibited by what G proteins?

A

s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Platelet granule release occurs after ______.

A

adhesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the 3 types of granules?

A
  • alpha
  • dense
  • lysosomal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is platelet adhesion?

A

Platelets bind to damaged area via GP Ib and GP VI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is platelet aggregation?

A

fibrinogen binds to activated GP IIb/IIIa receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Platelets meshed in fibrin is called what?

A

hemostatic plug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is a hemostatic plug made up of?

A

platelets and fibrin mesh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the indications for antiplatelet agents?

A
  • cerebrovascular disease
  • ACS/ unstable angina
  • PAD
  • CABG or PCI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the antiplatelet agents?

A
  • ASA
  • thienopyridines
  • GP IIb/IIIa antagonists
  • Phosphodiesterase inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the thienopyridine agents?

A
  • clopidogrel (Plavix)

- prasugrel (Effient)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the GP IIb/IIIa inhibitors?

A
  • abciximab (Reopro)
  • eptifibatide (Integrilin)
  • tirofiban (Aggrastat)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the MOA of ASA?

A

Acetylation at Ser529 results in irreversible inhibition of COX-1 for the life of the platelet.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

High doses of ASA inhibit what?

A

both COX-1 and COX-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Why are lower doses of ASA effective for antiplatelet response?

A
  • inhibition of platelet COX-1 occurs at lower doses than inhibition of COX-2 in the vessel wall
  • platelets have no nucleus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What is the onset of action for platelet inhibition with ASA?
~ 5 minutes
26
What is the duration of antiplatelet action with ASA?
7-10 days
27
What are the ADRs with ASA?
- GI upset | - bleeding
28
ASA therapy in combination with _______ can inhibit the site of action for ASA and reduce its antiplatelet effects.
other NSAIDs
29
What is the MOA of thienopyridines?
- irreversible antagonist of platelet P2Y12 ADP receptors | - the P2Y12 receptor couples to Gi to inhibit adenylyl cyclase
30
What is the route of administration of clopidogrel?
oral
31
Maximal platelet inhibition occurs within _______ of oral administration of clopidogrel.
5-7 days
32
Antiplatelet effects of clopidogrel persist for _______ after discontinuing.
4-8 days
33
Clopidogrel is a prodrug. (T/F)
True
34
Clopidogrel is a preferred agent because it has very little variation among patients. (T/F)
False: variability is an issue with clopidogrel
35
Prasugrel is a prodrug. (T/F)
True
36
What is the route of administration of prasugrel?
oral
37
Prasugrel requires hepatic conversion to an active metabolite. (T/F)
True
38
Which thienopyridine has the quickest onset of action?
prasugrel
39
Clopidogrel is considered more efficacious for ACS than Ticagrelor. (T/F)
False: ticagrelor is considered more efficacious
40
Ticagrelor requires hepatic conversion to an active metabolite. (T/F)
False: no required metabolic activation
41
What is the route of administration of ticagrelor?
oral
42
Ticagrelor is not a thienopyridine. (T/F)
True
43
Ticagrelor irreversibly binds to the platelet P2Y12 receptor. (T/F)
False: reversibly
44
Cangrelor is a reversible P2Y12 receptor antagonist. (T/F)
True
45
What is the route of administration of cangrelor?
IV
46
Cangrelor is not a thienopyridine. (T/F)
True
47
Cangrelor requires hepatic activation. (T/F)
False
48
The antiplatelet effects of cangrelor are reversed ________(slowly/quickly) after stopping infusion.
quickly
49
What is cangrelor FDA approved for?
Adjunct during PCI to reduce thrombosis
50
What is the MOA of GP IIb/IIIa antagonists?
Inhibits binding of fibrinogen to the activated GP IIb/IIIa receptor to prevent platelet aggregation.
51
Monoclonal antibody that binds GP IIb/IIIa receptor
abciximab
52
reversible RGD-mimetic peptide that binds GP IIb/IIIa receptor
eptifibatide
53
reversible non peptide RGD-mimetic that binds GP IIb/IIIa receptor
tirofiban
54
What is the route of administration for GP IIb/IIIa inhibitors?
IV
55
What is the onset of action for GP IIb/IIIa inhibitors?
minutes
56
What is the duration of action for GP IIb/IIIa inhibitors?
abciximab: up to 72 hours | eptifibatide and tirofiban 4-6 hours
57
GP IIb/IIIa inhibitors are often used in combination with _______ during PCI.
clopidogrel
58
What is the main ADR of GP IIb/IIIa inhibitors?
bleeding
59
GP IIb/IIIa inhibitors are available as oral formulation. (T/F)
False
60
What are the anticoagulant phosphodiesterase inhibitor agents?
- Aggrenox - Persantine - Cilostazol
61
What are the components of Aggrenox?
- aspirin 25 mg | - dipyridamole ER 200 mg
62
What is Aggrenox indicated for?
ischemic stroke and TIA
63
What are the components of Persantine?
dipyridamole only: not effective antiplatelet
64
What is Cilostazol approved for?
intermittent claudication
65
What is the MOA for Vorapaxar?
protease-activated receptor-1 (PAR-1) antagonist
66
What is Vorapaxar approved for?
reduce trombosis in patients with previous MI or PAD
67
What is the route of administration of Vorapaxar?
oral
68
Why is Vorapaxar considered to have irreversible effects?
While the antagonism is reversible, the half-life is so long (8 days) that it is considered to be irreversible because the life span of a platelet is 8-9 days.
69
What are the contraindications for Vorapaxar?
- history of stroke or TIA - intracranial hemorrhage - current active bleeding